Status:
COMPLETED
Assessment of the Effect of Food on ABT-143 Bioavailability
Lead Sponsor:
AstraZeneca
Conditions:
Pharmacokinetic Variables
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
Single-dose, open-label, two-period crossover study of ABT-143
Eligibility Criteria
Inclusion
- 18-55 years of age (inclusive)
- BMI 19 to 29 inclusive
Exclusion
- Asian ancestry
- Concurrent participation in another study
- Females pregnant or breastfeeding
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT00719693
Start Date
July 1 2008
Last Update
September 28 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Site Reference ID/Investigator# 9242
Evansville, Indiana, United States, 47710